Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Use of Visual Decision Aid for Shared Decision Making in Chest Pain

12 april 2022 uppdaterad av: National University Hospital, Singapore

The Use of a Visual Decision Aid for Shared Decision Making Among Patients With Chest Pain

This study aims to evaluate the use of the chest pain choice (CPC) decision aid as a tool to facilitate discussion between the patient and his/her attending physician with regard to subsequent management plans. Patients aged 21 years and above with low-risk chest pain, as determined by the HEART score (HEART score 0-3), will be included. The investigator's hypothesis is that incorporating the Chest Pain Choice visual aid in shared decision making can help to reduce unnecessary admissions for low risk chest pain to the observation ward, as well as increase patient knowledge with regards to their own condition.

Studieöversikt

Detaljerad beskrivning

Chest pain is a common presenting complaint in the Emergency Department (ED). Cardiac testing in low-risk patients poses unnecessary costs and resource utilisation, which may in part be due to clinicians adopting a very-low-risk threshold for discharge without testing.

The Chest Pain Choice (CPC) decision aid is a visual aid that was developed to facilitate shared decision-making between physicians and patients who present to the emergency department with chest pain, and has shown to be effective in increasing patient knowledge and decreasing the rate of admission to an observation unit for cardiac testing, among patients with chest pain who are at low risk for acute coronary syndromes. Shared decision making with the use of this visual aid has been shown in other centres to be associated with greater patient knowledge, greater patient involvement in decision making and less frequent admissions, with no increase in major adverse cardiac events (MACE) due to the intervention.

The visual aid includes a brief description of what tests have been done thus far to assess the patient's risk of MACE, a graphic representation of the risk as calculated based on the HEART score, as well as the evaluation options available. The visual aid has been modified from its original form for the local context in terms of viable options for further evaluation.

This study aims to assess if using a visual decision aid for shared decision making between physician and patient can safely help to decrease unnecessary admissions to the ED observation unit, as well as its impact on patient knowledge, satisfaction, as well as 30-day and 60-day Major Adverse Cardiac Events (MACE).

Studietyp

Interventionell

Inskrivning (Faktisk)

18

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Central
      • Singapore, Central, Singapore, 119074
        • Mui Teng Chua

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

21 år till 99 år (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Aged 21 years and above
  • Have low risk chest pain as defined by the HEART score (0-3 points)
  • Be English-literate
  • Have an initial serum troponin that is less than the 99th centile of the normal reference population
  • Have an initial electrocardiogram that is not suggestive of cardiac ischaemia

Exclusion Criteria:

  • Have a HEART score of 4 or more
  • Are not English-literate
  • Have an elevated initial serum troponin
  • Have an initial electrocardiogram that is suggestive of cardiac ischaemia (ST-segment depression or elevation, new onset left bundle brunch block, T-wave inversions, etc.)
  • Have known coronary artery disease
  • Have a prior plan for cardiac intervention or admission
  • Have barriers to outpatient follow-up
  • Are prisoners
  • Are pregnant
  • Are hearing or visually impaired, or are otherwise unable to use the clinical decision aid
  • Do not consent to participation in the study

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Övrig
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Intervention Arm
Patients in the intervention arm will receive the Chest Pain Choice visual aid prior to discussion with their primary physician regarding disposition.
The Chest Pain Choice (CPC) decision aid is a visual aid that was developed to facilitate shared decision-making between physicians and patients who present to the emergency department with chest pain. The visual aid includes a brief description of what tests have been done thus far to assess the patient's risk of MACE, a graphic representation of the risk as calculated based on the HEART score, as well as the evaluation options available. The visual aid has been modified from its original form for the local context in terms of viable options for further evaluation.
Inget ingripande: Control Arm
Patients in the control arm will not receive the Chest Pain Choice visual aid and will receive standard care.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Admission to the Emergency Department Observation Unit
Tidsram: Index visit
Admission to the Emergency Department Observation Unit during index emergency department visit
Index visit

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Major Adverse Cardiac Events (MACE) at 30 days
Tidsram: 30 days after index visit
MACE is defined as all-cause mortality, myocardial infarction or coronary revascularisation.
30 days after index visit
Major Adverse Cardiac Events at 60 days
Tidsram: 60 days after index visit
MACE is defined as all-cause mortality, myocardial infarction or coronary revascularisation.
60 days after index visit
Emergency Department Attendance at 30 days
Tidsram: 30 days after index visit
Repeat attendance to the emergency department
30 days after index visit
Emergency Department Attendance at 60 days
Tidsram: 60 days after index visit
Repeat attendance to the emergency department
60 days after index visit
Stress treadmill electrogram at 30 days
Tidsram: 30 days after index visit
The presence of stress treadmill electrocardiogram at 30 days post index visit
30 days after index visit
Stress treadmill electrogram at 60 days
Tidsram: 60 days after index visit
The presence of stress treadmill electrocardiogram at 60 days post index visit
60 days after index visit
Stress myocardial perfusion imaging at 30 days
Tidsram: 30 days after index visit
The presence of stress myocardial perfusion imaging at 30 days post index visit
30 days after index visit
Stress myocardial perfusion imaging at 60 days
Tidsram: 60 days after index visit
The presence of stress myocardial perfusion imaging at 60 days post index visit
60 days after index visit
Stress echocardiogram at 30 days
Tidsram: 30 days after index visit
The presence of stress echocardiogram at 30 days post index visit
30 days after index visit
Stress echocardiogram at 60 days
Tidsram: 60 days after index visit
The presence of stress echocardiogram at 60 days post index visit
60 days after index visit
Computed tomography of the coronary arteries (CTCA) at 30 days
Tidsram: 30 days after index visit
The presence of computed tomography of the coronary arteries (CTCA) at 30 days post index visit
30 days after index visit
Computed tomography of the coronary arteries (CTCA) at 60 days
Tidsram: 60 days after index visit
The presence of computed tomography of the coronary arteries (CTCA) at 60 days post index visit
60 days after index visit

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

1 mars 2019

Primärt slutförande (Faktisk)

3 september 2021

Avslutad studie (Faktisk)

3 september 2021

Studieregistreringsdatum

Först inskickad

26 augusti 2018

Först inskickad som uppfyllde QC-kriterierna

14 september 2018

Första postat (Faktisk)

17 september 2018

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

20 april 2022

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

12 april 2022

Senast verifierad

1 augusti 2021

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Kliniska prövningar på Hjärtinfarkt

Kliniska prövningar på Chest Pain Choice visual aid

3
Prenumerera